Ibrexafungerp Citrate
Specifications
1965291-08-0CAS Number
(1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid;2-hydroxypropaIUPAC Name
C50H75N5O11Chemical Formula
922.2 g/molMolecular Weight
Ibrexafungerp citrate; 1965291-08-0; SCY-078 citrate; M4NU2SDX3E; brexafemme; UNII-M4NU2SDX3E; 4H-1,4a-Propano-2H-phenanthro(1,2-C)pyran-7-carboxylic acid, 15-((2R)-2-amino-2,3,3-trimethylbutoxy)-8-((1R)-1,2-dimethylpropyl)-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-(5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl)-, (1S,4aR,6as; 4H-1,4A-PROPANO-2H-PHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID, 15-((2R)-2-AMINO-2,3,3-TRIMETHYLBUTOXY)-8-((1R)-1,2-DIMETHYLPROPYL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-1,6A,8,10A-TETRAMETHYL-14-(5-(4-PYRIDINYL)-1H-1,2,4-TRIAZOL-1-YL)-, (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1); RefChem:56933; (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-15-((2R)-2-AMINO-2,3,3-TRIMETHYLBUTOXY)-1,6A,8,10A-TETRAMETHYL-8-((2R)-3-METHYLBUTAN-2-YL)-14-(5-(PYRIDIN-4-YL)-1H-1,2,4-TRIAZOL-1-YL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-2H,4H-1,4A-PROPANOPHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID COMPOUND WITH 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID (1:1); Ibrexafungerp citrate [USAN]; Ibrexafungerp (citrate); (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-15-[(2R)- 2-amino-2,3,3-trimethylbutoxy]-1,6a,8,10a-tetramethyl-8- [(2R)-3-methylbutan-2-yl]-14-[5-(pyridin-4-yl)-1H-1,2,4- triazol-1-yl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-2H,4H-1,4a-propanophenanthro[1,2-c]pyran-7-carboxylic acid compound with 2-hydroxypropane-1,2,3-tricarboxylic acid; Ibrexafungerp citrate (USAN); Brexafemme (TN); Ibrexafungerp citrate?; orb1739451; CHEMBL4298168; SCHEMBL29404341; EX-A7291A; GLXC-26020; IBREXAFUNGERP CITRATE [WHO-DD]; HY-107126A; IBREXAFUNGERP CITRATE [ORANGE BOOK]; CS-0146666; D11545; G91326; (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid;2-hydroxypropane-1,2,3-tricarboxylic acid; (1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-2-((R)-2-amino-2,3,3-trimethylbutoxy)-1,6a,8,10a-tetramethyl-8-((R)-3-methylbutan-2-yl)-3-(5-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid--2-hydroxypropane-1,2,3-tricarboxylic acid (1/1); (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-15-((2R)- 2-AMINO-2,3,3-TRIMETHYLBUTOXY)-1,6A,8,10A-TETRAMETHYL-8- ((2R)-3-METHYLBUTAN-2-YL)-14-(5-(PYRIDIN-4-YL)-1H-1,2,4- TRIAZOL-1-YL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-2H,4H-1,4A-PROPANOPHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID COMPOUND WITH 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID (1:1)Synonyms
